CRNX
Crinetics Pharmaceuticals, Inc.
NASDAQ · Healthcare · Biotechnology · US
$84.95
+0.00%Margins
Gross margin
99.2%
EBITDA margin
-1206.9%
EBIT margin
-1302.5%
Net margin
-1189.9%
FCF margin
-1008.6%
-42.1%
Return on equity
-37.9%
Return on assets
-44.3%
Return on invested capital
0.03x
Asset turnover
-$422.5M
Cash from operations
$11
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026